Literature DB >> 12962950

Successful term pregnancy after bilateral uterine artery embolization for postpartum hemorrhage.

Hsin Wang1, Sara Garmel.   

Abstract

BACKGROUND: Selective bilateral uterine artery embolization has been used since the 1970s for the conservative treatment of postpartum hemorrhage. The fertility rate after the embolization procedure is yet to be determined. CASE: A 30-year-old woman presented with placental abruption and subsequently delivered preterm at 29 weeks' gestation. Her delivery was complicated by postpartum hemorrhage, for which selective bilateral uterine artery embolization was performed with successful cessation of the hemorrhage. Three months later, the patient presented with a spontaneous pregnancy. Her pregnancy resulted in an appropriately grown fetus delivered at 39 weeks' gestation.
CONCLUSION: This is one of the earliest reported successful pregnancies after a bilateral uterine artery embolization procedure performed for postpartum hemorrhage. This case adds to a growing literature demonstrating that pregnancy after embolization is possible, and can occur soon after the procedure.

Entities:  

Mesh:

Year:  2003        PMID: 12962950     DOI: 10.1016/s0029-7844(03)00230-8

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  3 in total

Review 1.  Short & long term adverse outcomes after arterial embolisation for the treatment of postpartum haemorrhage: a systematic review.

Authors:  Marie-Aimée Päivi Soro; Alban Denys; Maud de Rham; David Baud
Journal:  Eur Radiol       Date:  2016-05-26       Impact factor: 5.315

2.  A change in the management of intractable obstetrical hemorrhage over 15 years in a tertiary care center.

Authors:  Sunil K Juneja; Pooja Tandon; Bishav Mohan; Sandeep Kaushal
Journal:  Int J Appl Basic Med Res       Date:  2014-09

3.  Risk Factor for Residue After Uterine Artery Chemotherapy and Embolization in Combination with Dilatation and Curettage for Treating Caesarean Scar Pregnancy.

Authors:  Feng Cheng; Dan Shan; Sijia Guo; Shuang Cheng; Hongwei Yang; Jialin Han; Tongxiu Hu
Journal:  Curr Mol Med       Date:  2019       Impact factor: 2.222

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.